Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term safety of febuxostat, once daily
(QD), compared to allopurinol in reducing serum urate levels in subjects with gout.